Polyclonal activation of B lymphocytes by lipopolysaccharide requires macrophage-derived interleukin-1BUCALA, R.Immunology (Oxford). 1992, Vol 77, Num 4, pp 477-482, issn 0019-2805Article

Macrophage migration inhibitory factor : A counter-regulator of glucocorticoid action and critical mediator of septic shockCALANDRA, T; BUCALA, R.Journal of inflammation. 1995, Vol 47, Num 1-2, pp 39-51, issn 1078-7852Conference Paper

Characterization of antisera to the addition product formed by the nonenzymatic reaction of 16α-hydroxyestrone with albuminBUCALA, R; CERAMI, A.Molecular immunology. 1983, Vol 20, Num 12, pp 1289-1292, issn 0161-5890Article

Inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity by dopachrome analogsXINI ZHANG; BUCALA, R.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 22, pp 3193-3198, issn 0960-894XArticle

Advanced glycosylation end products in diabetic renal and vascular diseaseBUCALA, R; VLASSARA, H.American journal of kidney diseases. 1995, Vol 26, Num 6, pp 875-888, issn 0272-6386Article

A role for the endocrine and pro-inflammatory mediator MIF in the control of insulin secretion during stressWAEBER, G; CALANDRA, T; BONNY, C et al.Diabetes/metabolism research and reviews (Print). 1999, Vol 15, Num 1, pp 47-54, issn 1520-7552Article

Pathogenic effects of advanced glycosylation : biochemical, biologic, and clinical implications for diabetes and agingVLASSARA, H; BUCALA, R; STRIKER, L et al.Laboratory investigation. 1994, Vol 70, Num 2, pp 138-151, issn 0023-6837Article

Modification of DNA by reducing sugars: a possible mechanism for nucleic acid aging and age-related dysfunction in gene expressionBUCALA, R; MODEL, P; CERAMI, A et al.Proceedings of the National Academy of Sciences of the United States of America. Biological sciences. 1984, Vol 81, Num 1, pp 105-109, issn 0273-1134Article

Nonenzymatic addition of glucocorticoids to lens proteins in steroid-induced cataractsMANABE, S; BUCALA, R; CERAMI, A et al.The Journal of clinical investigation. 1984, Vol 74, Num 5, pp 1803-1810, issn 0021-9738Article

Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblastsBUCALA, R; RITCHLIN, C; WINCHESTER, R et al.The Journal of experimental medicine. 1991, Vol 173, Num 3, pp 569-574, issn 0022-1007, 6 p.Article

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetesBUCALA, R; TRACEY, K. J; CERAMI, A et al.The Journal of clinical investigation. 1991, Vol 87, Num 2, pp 432-438, issn 0021-9738Article

The reaction 16α-hydroxyestrone with erythrocytes in vitro and in vivoBUCALA, R; FISHMAN, J; CERAMI, A et al.European journal of biochemistry (Print). 1984, Vol 140, Num 3, pp 593-598, issn 0014-2956Article

Assignment¹ of the histone deacetylase gene (Hdac3) to mouse chromosome 18B3 by in situ hybridizationMAHLKNECHT, U; BUCALA, R; VERDIN, E et al.Cytogenetics and cell genetics. 1999, Vol 84, Num 3-4, pp 192-193, issn 0301-0171Article

Immunochemical detection of advanced glycosylation end products in vivoMAKITA, Z; VLASSARA, H; CERAMI, A et al.The Journal of biological chemistry (Print). 1992, Vol 267, Num 8, pp 5133-5138, issn 0021-9258Article

Transposition of an Alu-containing element induced by DNA-advanced glycosylation endproductsBUCALA, R; LEE, A. T; ROURKE, L et al.Proceedings of the National Academy of Sciences of the United States of America. 1993, Vol 90, Num 7, pp 2666-2670, issn 0027-8424Article

Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritisLEECH, M; METZ, C; BUCALA, R et al.Arthritis and rheumatism. 2000, Vol 43, Num 4, pp 827-833, issn 0004-3591Article

The macrophage is an important and previously urecognized source of macrophage migration inhibitory factorCALANDRA, T; BERNHAGEN, J; MITCHELL, R. A et al.The Journal of experimental medicine. 1994, Vol 179, Num 6, pp 1895-1902, issn 0022-1007Article

Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbitPANAGIOTOPOULOS, S; O'BRIEN, R. C; BUCALA, R et al.Atherosclerosis. 1998, Vol 136, Num 1, pp 125-131, issn 0021-9150Article

Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatmentSOULIS, T; COOPER, M. E; VRANES, D et al.Kidney international. 1996, Vol 50, Num 2, pp 627-634, issn 0085-2538Conference Paper

Immunohistochemical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathyNISHINO, T; HORII, Y; SHIIKI, H et al.Human pathology. 1995, Vol 26, Num 3, pp 308-313, issn 0046-8177Article

A role for DNA mutations in diabetes-associated teratogenesis in transgenic embryosLEE, A. T; PLUMP, A; DESIMONE, C et al.Diabetes (New York, NY). 1995, Vol 44, Num 1, pp 20-24, issn 0012-1797Article

Structure of lysine adducts with 16α-hydroxyestrone and cortisolBUCALA, R; ULRICH, P. C; CHAIT, B. T et al.Journal of steroid biochemistry. 1986, Vol 25, Num 1, pp 127-133, issn 0022-4731Article

Identification of N²-(1-carboxymethyl)guanine (CMB) as a guanine advanced glycation end productAL-ABED, Y; SCHLEICHER, E; VOELTER, W et al.Bioorganic & medicinal chemistry letters (Print). 1998, Vol 8, Num 16, pp 2109-2110, issn 0960-894XArticle

Macrophage migration inhibitory factor (MIF) : potential perspectives for immune-intervention in renal diseaseATKINS, R. C; NIKOLIC-PATERSON, D. J; BUCALA, R et al.Nephrology, dialysis, transplantation (Print). 1998, Vol 13, Num 11, pp 2719-2720, issn 0931-0509Article

Page / 2